The FTC approved Ascension’s $3.9 billion acquisition of AmSurg, the nation’s largest independent ambulatory surgery center operator, under a consent order issued June 2, 2026. To preserve competition,…
Independent orthopedic practices across the U.S. are reducing Medicare exposure — and in some cases dropping it entirely — as reimbursement rates fail to keep pace with rising…
Health systems in 2026 are applying a “buy, sell, or fight” calculus to market strategy — acquiring where they can build density, divesting where they’re subscale, and competing…
Planet DDS’s “2026 Dental Industry Outlook: Deep Dive” analyzed more than 8,500 dental practices and found a deepening divide: one-third grew by more than 10% last year, while…
Private equity investment in medical spas remained disciplined in 2025, with add-on acquisitions dominating over headline deals and valuations ranging from 3x to 6x EBITDA for smaller practices…
Systematic value creation planning has become a non-negotiable discipline for PE-backed healthcare companies. Dan Cremons, a former private equity investor and CEO-turned-advisor, argues that the old PE playbook…
April 2026 saw 15+ DSO M&A transactions tracked by Group Dentistry Now. TUSK Practice Sales advised Oak Tree Pediatric Dentistry’s sale to Chord Specialty Dental Partners and Comella…
DSOs in 2026 face four disruptors reshaping competitive strategy across the dental sector. Private equity investment is resurging — oral surgery is the only dental specialty that avoided…
Five Becker’s Healthcare resources address the operational pressures health system leaders face this week: AI in oncology care pathways — with real-world implementation from St. Elizabeth Healthcare and…
The Trump administration announced it will withhold $1.3 billion in Medicaid funding from California—the largest single deferral ever made by CMS—citing the state’s failure to address program integrity…
